{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:30:37Z","timestamp":1795188637696,"version":"4.10.3"},"reference-count":91,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.waojou.2024.100935","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T17:13:15Z","timestamp":1721495595000},"page":"100935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The systemic treatments for drug reaction with eosinophilia and systemic symptoms (DRESS) beyond corticosteroids"],"prefix":"10.1016","volume":"17","author":[{"given":"Sifan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6234-1554","authenticated-orcid":false,"given":"Hongzhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaad.2023.02.072","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis","volume":"90","author":"Wei","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jdermsci.2007.05.013","article-title":"T\u00a0cell populations propagating in the peripheral blood of patients with drug eruptions","volume":"48","author":"Nishio","year":"2007","journal-title":"J\u00a0Dermatol Sci"},{"issue":"12","key":"10.1016\/j.waojou.2024.100935_bib5","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.waojou.2024.100935_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1108345","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review","volume":"10","author":"Manieri","year":"2023","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib7","doi-asserted-by":"crossref","first-page":"709 e1","DOI":"10.1016\/j.jaad.2013.01.032","article-title":"DRESS syndrome: Part II. Management and therapeutics","volume":"68","author":"Husain","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib8","first-page":"139","article-title":"Drug reaction with eosinophilia and\u00a0systemic symptoms (DRESS): incidence, pathogenesis and management","volume":"16","author":"Shiohara","year":"2017","journal-title":"Expet Opin Drug Saf"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399400001769","article-title":"Molecular targets for existing and novel immunosuppressive drugs","volume":"2","author":"Stepkowski","year":"2000","journal-title":"Expet Rev Mol Med"},{"issue":"6","key":"10.1016\/j.waojou.2024.100935_bib10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.02.063","article-title":"The use of cyclosporine in dermatology: part I","volume":"63","author":"Amor","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.waojou.2024.100935_bib11","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1111\/1346-8138.14207","article-title":"Short course of cyclosporin A as a treatment option for drug-induced hypersensitivity syndrome: case reports and review of the published work","volume":"45","author":"Hashizume","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.waojou.2024.100935_bib12","doi-asserted-by":"crossref","DOI":"10.2196\/41391","article-title":"Cyclosporine in the treatment of drug reaction with eosinophilia and systemic symptoms syndrome: retrospective cohort study","volume":"6","author":"Zita","year":"2023","journal-title":"JMIR Dermatol."},{"issue":"6","key":"10.1016\/j.waojou.2024.100935_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jamadermatol.2020.0048","article-title":"Evaluation of cyclosporine for the treatment of DRESS syndrome","volume":"156","author":"Nguyen","year":"2020","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/ajd.13982","article-title":"Comparison of cyclosporine and systemic corticosteroid for treating drug reaction with eosinophilia and systemic symptoms syndrome: a retrospective 20-year single-centre study in South Korea","volume":"64","author":"Kwon","year":"2023","journal-title":"Australas J Dermatol"},{"issue":"11","key":"10.1016\/j.waojou.2024.100935_bib15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamadermatol.2016.2220","article-title":"Cyclosporine treatment of drug-induced hypersensitivity syndrome","volume":"152","author":"Kirchhof","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.waojou.2024.100935_bib16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.anai.2021.08.012","article-title":"Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine","volume":"127","author":"Su","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaad.2008.08.049","article-title":"Mycophenolate mofetil in dermatology","volume":"60","author":"Orvis","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaad.2010.12.013","article-title":"Fulminant myocarditis as a late sequela of DRESS: two cases","volume":"65","author":"Bourgeois","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib19","article-title":"Treatment of drug reaction with eosinophilia and systemic symptoms (dress) with mycophenolate mofetil as a steroid-sparing agent","volume":"113","author":"Mortezavi","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2009.05.046","article-title":"Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis","volume":"62","author":"Shaughnessy","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.waojou.2024.100935_bib21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1177\/0961203306071431","article-title":"Primary lymphoma of CNS, mycophenolate mofetil and lupus","volume":"15","author":"Finelli","year":"2006","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ajd.12406","article-title":"Cyclophosphamide in dermatology","volume":"58","author":"Kim","year":"2017","journal-title":"Australas J Dermatol"},{"issue":"8","key":"10.1016\/j.waojou.2024.100935_bib23","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1080\/08820139.2019.1588291","article-title":"The immuno-enhancement effects of tubiechong (eupolyphaga sinensis) lyophilized powder in cyclophosphamide-induced immunosuppressed mice","volume":"48","author":"Liu","year":"2019","journal-title":"Immunol Invest"},{"issue":"3","key":"10.1016\/j.waojou.2024.100935_bib24","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1053\/j.ajkd.2009.10.054","article-title":"Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivation","volume":"55","author":"Laban","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.waojou.2024.100935_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-242240","article-title":"Successful mepolizumab treatment for DRESS-induced refractory eosinophilic myocarditis and concurrent thyroiditis","volume":"14","author":"Truong","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","article-title":"Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis","volume":"124","author":"Talar-Williams","year":"1996","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.waojou.2024.100935_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.7326\/0003-4819-150-3-200902030-00027","article-title":"Hypersensitivity myocarditis associated with azithromycin exposure","volume":"150","author":"Pursnani","year":"2009","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.waojou.2024.100935_bib28","first-page":"1353","article-title":"[Drug rash with eosinophilia and systemic symptoms (DRESS) attributed to the oral skin-care supplement Imedeen]","volume":"149","author":"van Leeuwen","year":"2005","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.waojou.2024.100935_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jdcr.2022.08.015","article-title":"Jaundice and morbilliform eruption in a 20-year-old female","volume":"31","author":"Biglione","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-024-00514-0","article-title":"Severe cutaneous adverse reactions","volume":"10","author":"Hung","year":"2024","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaip.2013.11.008","article-title":"Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms","volume":"2","author":"Galvao","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib32","article-title":"Skin reaction with eosinophilia and systemic symptoms after lenalidomide in peritoneal dialysis","volume":"39","author":"Cazzato","year":"2022","journal-title":"G\u00a0Ital Nefrol"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2340\/00015555-1168","article-title":"High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome","volume":"92","author":"Kito","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib34","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jaip.2017.10.016","article-title":"Successful intravenous immunoglobulin treatment in pediatric severe DRESS syndrome","volume":"6","author":"Marcus","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archderm.148.4.dlt120002-c","article-title":"Poor benefit\/risk balance of intravenous immunoglobulins in DRESS","volume":"148","author":"Joly","year":"2012","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib36","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/bjd.14677","article-title":"Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms","volume":"175","author":"Takehara","year":"2016","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaad.2012.10.017","article-title":"Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution","volume":"68","author":"Ushigome","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.waojou.2024.100935_bib38","article-title":"Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome","volume":"2018","author":"Morita","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.waojou.2024.100935_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/CRIAI:29:3:173","article-title":"Intravenous immunoglobulin: adverse effects and safe administration","volume":"29","author":"Orbach","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.waojou.2024.100935_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1134178","article-title":"Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome","volume":"14","author":"Rubin","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/jdv.18808","article-title":"Management and treatment outcome of DRESS patients in Europe: an international multicentre retrospective study of 141 cases","volume":"37","author":"Kridin","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.waojou.2024.100935_bib42","article-title":"Anti-IL-5 therapies for asthma","volume":"7","author":"Farne","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.waojou.2024.100935_bib43","first-page":"1","article-title":"Treatment with IL5-\/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"23","author":"Gschwend","year":"2022","journal-title":"Allergo J Int"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2014.01.007","article-title":"TNF-alpha as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"74","author":"Uno","year":"2014","journal-title":"J\u00a0Dermatol Sci"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jdcr.2017.05.006","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) successfully treated with tumor necrosis factor-alpha inhibitor","volume":"3","author":"Leman","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib46","article-title":"Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration","volume":"8","author":"Maximova","year":"2020","journal-title":"J\u00a0Immunother Cancer"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib47","first-page":"418","article-title":"Corticosteroid-induced drug reaction with eosinophilia and systematic symptoms successfully treated with a tumor necrosis factor alpha inhibitor","volume":"40","author":"Kim","year":"2022","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/ski2.185","article-title":"Etanercept leads to a rapid recovery of a Dabrafenib-\/Trametinib-associated toxic epidermal necrolysis-like severe skin reaction","volume":"3","author":"Yordanova","year":"2023","journal-title":"Skin Health Dis"},{"issue":"2-3","key":"10.1016\/j.waojou.2024.100935_bib49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000475546","article-title":"Skin-homing IL-13-producing T cells expand in the circulation of patients with drug rash with eosinophilia and systemic symptoms","volume":"233","author":"Teraki","year":"2017","journal-title":"Dermatology"},{"issue":"12","key":"10.1016\/j.waojou.2024.100935_bib50","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/j.jaip.2023.08.028","article-title":"Dupilumab to treat drug reaction with eosinophilia and systemic symptoms: a case series","volume":"11","author":"Dubin","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.18176\/jiaci.0944","article-title":"Dupilumab as effective therapy for corticosteroid- dependent\/resistant type 2 inflammation-related cutaneous adverse reactions","volume":"34","author":"Shen","year":"2024","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40257-020-00583-3","article-title":"Effect of dupilumab on laboratory parameters in adolescents with atopic dermatitis: results from a randomized, placebo-controlled, phase 3 clinical trial","volume":"22","author":"Siegfried","year":"2021","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaip.2023.09.036","article-title":"The usefulness of omalizumab in low response to corticosteroids DRESS syndrome: a case series","volume":"12","author":"Ben Said","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/jid.2008.192","article-title":"B-cell-directed therapy for inflammatory skin diseases","volume":"129","author":"Nagel","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"issue":"11","key":"10.1016\/j.waojou.2024.100935_bib55","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/cea.13252","article-title":"Monocytes are involved in the balance between regulatory T cells and Th17 cells in severe drug eruptions","volume":"48","author":"Ushigome","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdermsci.2016.05.001","article-title":"Preferential expression of CD134, an HHV-6 cellular receptor, on CD4T cells in drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"83","author":"Miyagawa","year":"2016","journal-title":"J\u00a0Dermatol Sci"},{"issue":"6","key":"10.1016\/j.waojou.2024.100935_bib57","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3465","article-title":"Correlation between expression of CD134, a human herpesvirus 6 cellular receptor, on CD4+ T cells and Th2-type immune responses in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"100","author":"Miyagawa","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"10.1016\/j.waojou.2024.100935_bib58","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jdcr.2019.07.004","article-title":"Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib","volume":"5","author":"Damsky","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib59","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41591-019-0733-7","article-title":"Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report","volume":"26","author":"Kim","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.waojou.2024.100935_bib60","doi-asserted-by":"crossref","first-page":"e945","DOI":"10.1542\/peds.2012-2117","article-title":"Severe DRESS syndrome managed with therapeutic plasma exchange","volume":"131","author":"Alexander","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib61","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1744-9987.2005.00320.x","article-title":"A\u00a0case of drug-induced hypersensitivity syndrome with multiple organ involvement treated with plasma exchange","volume":"9","author":"Higuchi","year":"2005","journal-title":"Ther Apher Dial"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib62","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.clindermatol.2020.04.014","article-title":"Thinking outside the box: is there a role for extracorporeal blood purification in DRESS syndrome complicated by acute kidney injury?","volume":"38","author":"Waldman","year":"2020","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic Apheresis in clinical practice - evidence-based approach from the writing committee of the American society for Apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J\u00a0Clin Apher"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine-a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.waojou.2024.100935_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/716458","article-title":"Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine","volume":"2008","author":"Chen","year":"2008","journal-title":"Mediat Inflamm"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib66","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.1997.tb02175.x","article-title":"Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine","volume":"136","author":"Redondo","year":"1997","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.waojou.2024.100935_bib67","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/j.1528-1167.2008.01720.x","article-title":"Anticonvulsant hypersensitivity syndrome: is there a role for immunomodulation?","volume":"49","author":"Cumbo-Nacheli","year":"2008","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.waojou.2024.100935_bib68","doi-asserted-by":"crossref","DOI":"10.1592\/phco.31.10.1043","article-title":"Successful treatment of sulfasalazine-induced DRESS syndrome with corticosteroids and -acetylcysteine","volume":"31","author":"Jose","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamadermatol.2023.4450","article-title":"Management of adult patients with drug reaction with eosinophilia and systemic symptoms: a delphi-based international consensus","volume":"160","author":"Bruggen","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.waojou.2024.100935_bib70","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1111\/jdv.19425","article-title":"Retrospective study on the association of human herpesvirus reactivation with severe DRESS: a description of blood and skin reactivations","volume":"37","author":"Marcombes","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib71","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jaip.2022.09.011","article-title":"Utility and safety of skin tests in drug reaction with eosinophilia and systemic symptoms (DRESS): a systematic review","volume":"11","author":"Teo","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib72","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jaip.2020.07.050","article-title":"Autoimmune hepatitis as a sequelae of oxcarbazepine-induced drug reaction with eosinophilia and systemic symptoms","volume":"9","author":"Droz","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib73","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaad.2023.02.073","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part II. Diagnosis and management","volume":"90","author":"Wei","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib74","doi-asserted-by":"crossref","first-page":"229","DOI":"10.18176\/jiaci.0480","article-title":"Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome","volume":"30","author":"Cabanas","year":"2020","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2024.100935_bib75","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2222.2011.03854.x","article-title":"Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor","volume":"42","author":"Molfino","year":"2012","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib76","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2230.2003.01267.x","article-title":"Persistent anticonvulsant hypersensitivity syndrome responding to ciclosporin","volume":"28","author":"Harman","year":"2003","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5414\/CNP64155","article-title":"Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment","volume":"64","author":"Zuliani","year":"2005","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.waojou.2024.100935_bib78","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3346\/jkms.2008.23.3.521","article-title":"Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs","volume":"23","author":"Lee","year":"2008","journal-title":"J\u00a0Kor Med Sci"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib79","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.leukres.2008.08.023","article-title":"Drug-induced hypersensitivity syndrome after bortezomib treatment for refractory multiple myeloma","volume":"33","author":"Hattori","year":"2009","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib80","doi-asserted-by":"crossref","first-page":"638 e1","DOI":"10.1016\/j.ajem.2011.02.018","article-title":"Acute myocardial infarction in a 56-year-old female patient treated with sulfasalazine","volume":"30","author":"Daoulah","year":"2012","journal-title":"Am J Emerg Med"},{"issue":"6","key":"10.1016\/j.waojou.2024.100935_bib81","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4103\/ijdvl.IJDVL_1084_16","article-title":"Treatment of drug-induced hypersensitivity syndrome with cyclosporine","volume":"83","author":"Zhang","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.waojou.2024.100935_bib82","first-page":"41","article-title":"Cyclosporine treatment of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report and brief review of the literature","volume":"2018","author":"Kuschel","year":"2018","journal-title":"Pract Dermatol"},{"issue":"11","key":"10.1016\/j.waojou.2024.100935_bib83","doi-asserted-by":"crossref","first-page":"492","DOI":"10.47102\/annals-acadmedsg.V47N11p492","article-title":"Relapsing course of sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by alopecia universalis and vitiligo","volume":"47","author":"Lian","year":"2018","journal-title":"Ann Acad Med Singapore"},{"issue":"6","key":"10.1016\/j.waojou.2024.100935_bib84","doi-asserted-by":"crossref","DOI":"10.5070\/D3266049312","article-title":"A\u00a0case of vancomycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome with failure to respond to cyclosporine treatment","volume":"26","author":"Clark","year":"2020","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.waojou.2024.100935_bib85","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaip.2019.06.020","article-title":"Severe acute hepatitis in drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome resolved following cyclosporine","volume":"8","author":"Ton","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2024.100935_bib86","first-page":"e80","article-title":"Valproic acid-induced DRESS in a child responding to cyclosporine with HLA analysis","volume":"120","author":"Ercan","year":"2022","journal-title":"Arch Argent Pediatr"},{"issue":"9","key":"10.1016\/j.waojou.2024.100935_bib87","article-title":"Recurrent leflunomide-induced drug reaction with eosinophilia and systemic symptom (DRESS) syndrome despite prolonged steroid taper: a case report","volume":"14","author":"Gayfield","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.waojou.2024.100935_bib88","article-title":"A\u00a0case of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient receiving peritoneal dialysis with Icodextrin exposure","volume":"14","author":"Alotaibi","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.waojou.2024.100935_bib89","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-250983","article-title":"Cyclosporine as an alternative immunosuppressant for steroid-resistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"16","author":"Tan","year":"2023","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib90","article-title":"Drug reaction with eosinophilia and systemic symptoms-associated perimyocarditis after initiation of anti-tuberculosis therapy: a case report","volume":"15","author":"Kong","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.waojou.2024.100935_bib91","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/ped.2023.0066","article-title":"Drug rash with eosinophilia and systemic symptoms syndrome caused by Itraconazole in a 17-year-old girl","volume":"36","author":"Pires Pereira","year":"2023","journal-title":"Pediatr Allergy Immunol Pulmonol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T00:09:42Z","timestamp":1724544582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455124000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":91,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1939455124000668"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2024.100935","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The systemic treatments for drug reaction with eosinophilia and systemic symptoms (DRESS) beyond corticosteroids","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2024.100935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100935"}}